Yesterday, the EVP, Chief Dev. Officer of Karyopharm Therapeutics (KPTI – Research Report), Ran Frenkel, sold shares of KPTI for
Tag: Ran Frenkel
The Chief Dev Operations Officer of Karyopharm Therapeutics (NASDAQ: KPTI) is Selling Shares
Yesterday, the Chief Dev Operations Officer of Karyopharm Therapeutics (NASDAQ: KPTI), Ran Frenkel, sold shares of KPTI for $55.73K. In